Assertio Holdings Inc (ASRT)
0.9971
+0.08
(+9.09%)
USD |
NASDAQ |
May 02, 15:07
Assertio Holdings Max Drawdown (5Y): 99.06% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
April 30, 2024 | 99.06% |
March 31, 2024 | 99.06% |
February 29, 2024 | 99.06% |
January 31, 2024 | 99.06% |
December 31, 2023 | 99.06% |
November 30, 2023 | 99.06% |
October 31, 2023 | 99.06% |
September 30, 2023 | 99.06% |
August 31, 2023 | 99.06% |
July 31, 2023 | 99.06% |
June 30, 2023 | 99.06% |
May 31, 2023 | 99.06% |
April 30, 2023 | 99.06% |
March 31, 2023 | 99.06% |
February 28, 2023 | 99.06% |
January 31, 2023 | 99.06% |
December 31, 2022 | 99.06% |
November 30, 2022 | 99.06% |
October 31, 2022 | 99.06% |
September 30, 2022 | 99.06% |
August 31, 2022 | 99.06% |
July 31, 2022 | 99.06% |
June 30, 2022 | 99.06% |
May 31, 2022 | 99.06% |
April 30, 2022 | 99.06% |
Date | Value |
---|---|
March 31, 2022 | 99.06% |
February 28, 2022 | 99.06% |
January 31, 2022 | 99.06% |
December 31, 2021 | 99.06% |
November 30, 2021 | 99.06% |
October 31, 2021 | 99.06% |
September 30, 2021 | 99.06% |
August 31, 2021 | 99.06% |
July 31, 2021 | 98.88% |
June 30, 2021 | 98.69% |
May 31, 2021 | 98.69% |
April 30, 2021 | 98.69% |
March 31, 2021 | 98.69% |
February 28, 2021 | 98.69% |
January 31, 2021 | 98.69% |
December 31, 2020 | 98.69% |
November 30, 2020 | 98.69% |
October 31, 2020 | 98.20% |
September 30, 2020 | 98.20% |
August 31, 2020 | 98.20% |
July 31, 2020 | 98.20% |
June 30, 2020 | 98.20% |
May 31, 2020 | 98.20% |
April 30, 2020 | 98.20% |
March 31, 2020 | 98.20% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
91.20%
Minimum
May 2019
99.06%
Maximum
Aug 2021
98.30%
Average
99.06%
Median
Aug 2021
Max Drawdown (5Y) Benchmarks
Ocular Therapeutix Inc | 94.06% |
Cormedix Inc | 93.38% |
Verastem Inc | 97.04% |
Puma Biotechnology Inc | 98.76% |
CytomX Therapeutics Inc | 96.52% |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | -57.57 |
Beta (5Y) | 0.997 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 101.5% |
Historical Sharpe Ratio (5Y) | -0.4576 |
Historical Sortino (5Y) | -0.9442 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 45.42% |